Suchergebnisse - "Genta, Sofia"

PubPharm (36)

1

Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT)

enthalten in: Journal of experimental & clinical cancer research : CR | 2023

von Genta, S. | Lajkosz, K. | Yee, N. | +18

2

Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Vieito, M. | Moreno, V. | Spreafico, A. | +18

3

Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials

enthalten in: JCO precision oncology | 2023

von Sanz-Garcia, E. | Genta, S. | Chen, X. | +9

4

Antibody-drug conjugates : in search of partners of choice

enthalten in: Trends in cancer | 2023

von Fuentes-Antrás, J. | Genta, S. | Vijenthira, A. | +1

5

Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers

enthalten in: International journal of molecular sciences | 2023

von Spiliopoulou, P. | Vornicova, O. | Genta, S. | +1

6

Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab

enthalten in: Journal for immunotherapy of cancer | 2022

von Watson, G. | Sanz-Garcia, E. | Zhang, W. | +19

7

Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients : A Post Hoc Analysis of the SAKK38/07 Study

enthalten in: Cancers | 2022

von Genta, S. | Ghilardi, G. | Cascione, L. | +13

8

Patient-derived cancer models : Valuable platforms for anticancer drug testing

enthalten in: Frontiers in oncology | 2022

von Genta, S. | Coburn, B. | Cescon, D. | +1

9

CANDIED : A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes Mellitus

enthalten in: Cancers | 2021

von Muniz, T. | Araujo, D. | Savage, K. | +13

10

Targeting the DNA damage response : PARP inhibitors and new perspectives in the landscape of cancer treatment

enthalten in: Critical reviews in oncology/hematology | 2021

von Genta, S. | Martorana, F. | Stathis, A. | +1